Atypical posterior reversible encephalopathy syndrome secondary to dasatinib

Detalles Bibliográficos
Autores principales: Nayak, Amiya Ranjan, Yadav, Deepika, Naranje, Priyanka, Dass, Jasmita, Kumar, Pradeep, Aggarwal, Mukul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548285/
https://www.ncbi.nlm.nih.gov/pubmed/37751924
http://dx.doi.org/10.5045/br.2023.2023057
_version_ 1785115242497310720
author Nayak, Amiya Ranjan
Yadav, Deepika
Naranje, Priyanka
Dass, Jasmita
Kumar, Pradeep
Aggarwal, Mukul
author_facet Nayak, Amiya Ranjan
Yadav, Deepika
Naranje, Priyanka
Dass, Jasmita
Kumar, Pradeep
Aggarwal, Mukul
author_sort Nayak, Amiya Ranjan
collection PubMed
description
format Online
Article
Text
id pubmed-10548285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-105482852023-10-05 Atypical posterior reversible encephalopathy syndrome secondary to dasatinib Nayak, Amiya Ranjan Yadav, Deepika Naranje, Priyanka Dass, Jasmita Kumar, Pradeep Aggarwal, Mukul Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023-09-30 2023-09-30 /pmc/articles/PMC10548285/ /pubmed/37751924 http://dx.doi.org/10.5045/br.2023.2023057 Text en © 2023 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Nayak, Amiya Ranjan
Yadav, Deepika
Naranje, Priyanka
Dass, Jasmita
Kumar, Pradeep
Aggarwal, Mukul
Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title_full Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title_fullStr Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title_full_unstemmed Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title_short Atypical posterior reversible encephalopathy syndrome secondary to dasatinib
title_sort atypical posterior reversible encephalopathy syndrome secondary to dasatinib
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548285/
https://www.ncbi.nlm.nih.gov/pubmed/37751924
http://dx.doi.org/10.5045/br.2023.2023057
work_keys_str_mv AT nayakamiyaranjan atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib
AT yadavdeepika atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib
AT naranjepriyanka atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib
AT dassjasmita atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib
AT kumarpradeep atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib
AT aggarwalmukul atypicalposteriorreversibleencephalopathysyndromesecondarytodasatinib

Ejemplares similares